vvus

Vivus Jumps 13% After Positive Research Report on Qnexa (VVUS)

Published on Mon, 04/04/2011 - 12:44
By FNNO Staff in General Interest, analysis, business, diet pills, financial, market, news, qnexa, stock, trading, vivus, vvus, News Update

Qnexa, taken once a day, helped reduce dependence on blood-pressure pills by as much at 19%, and decrease triglycerides by 26%, according to research presented yesterday.

No new safety risks were discovered among the 675 overweight and obese patients that participated in the study.

The FDA rejected Vivus' application for Qnexa last October, raising concerns the drug may cause heart risks and birth defects.

analysis, business, diet pills, financial, market, news, qnexa, stock, trading, vivus, vvus

Vivus Inc's (NASDAQ:VVUS) share price jumped after research showed its experimental diet pill Qnexa also helped lower blood pressure and cholesterol.

By FNNO Staff
fnnonline@gmail.com

Vivus Adds 12% in Early Trading on Qnexa Study Results

blood pressure, clinical study, diet, drug, fat, health, lipid, medical, medication, obesity, pharma, pill, placebo, qnexa, trade, vivus, vvus, weight loss

Vivus (VVUS) is up by double digits in early trading, after it says long-term data demonstrated patients treated with the investigational drug QNEXA for two years showed reductions in blood pressure and the use of antihypertensive

By FNNO Staff
fnnonline@gmail.com

The FDA Issues Health Advisory For Drug Topiramate (VVUS,JNJ

Published on Fri, 03/04/2011 - 15:44
By FNNO Staff in analysis, business, fda, financial, jnj, market, news, stock, topiramate, trading, vvus
vvus, jnj, topiramate, fda, financial, news, business, stock, trading, market, analysis

By FNNO Staff
fnnonline@gmail.com

Pre-Market Movers: January 21st, 2011

analysis, bac, bank of america, business, cytori therapeutics, cytx, danvers, financial, market, news, pbct, schlumberger, slm, stock, trading, vvus

Equity futures are pointing higher this morning with the Dow Jones Industrial Average looking to open 40 points higher while the broader S&P500 index is looking to open 6 points higher.

By FNNO Staff
fnnonline@gmail.com

Vivus Ordered to Provide Birth Defect Data for Qnexa to FDA

Published on Fri, 01/21/2011 - 09:18
By FNNO Staff in News corner, VVUS, birth defect, birth defects, business, down, fda, qnexa, shares, trade, vivus, vvus

VVUS' Qnexa has the component topimarate, used for seizures and migraine, and also has phentermine. The company stated that in its studies of 15 births from women exposed to Qnexa or topiramate, there were no reports of any fetal

birth defect, birth defects, business, down, fda, qnexa, shares, trade, vivus, vvus

Vivus Ordered to Provide Birth Defect Data for Qnexa to FDA"The U.S. Food and Drug Administration has ordered Vivus (VVUS) to release more information concerning birth defects associated with its experimental obesity drug before t

By FNNO Staff
fnnonline@gmail.com

Latest News from FNNO

Recent 52-Week Low Surpassed in Shares o...

Unisys (NYSE:UIS) traded at a new 52-week low today of $21.09. Approximately 5.1 milli ...

TransCanada: 52-Week High Recently Eclip...

TransCanada (NYSE:TRP) traded at a new 52-week high today of $51.46. So far today appr ...

Recent 52-Week High Exceeded in Shares o...

Shares of Trinity Industries (NYSE:TRN) traded today at $46.17, breaking its 52-week hi ...

Watch for Continued Gains in Shares of S...

Shares of Sasol (NYSE:SSL) traded today at $60.69, breaking its 52-week high. So far t ...

Shares of China Petroleum & Chemical Ris...

China Petroleum & Chemical (NYSE:SNP) traded today at a new 52-week high of $98.89. Ap ...

Saia Looks to Continue to Trade Above it...

Shares of Saia (NASDAQ:SAIA) traded at a new 52-week high today of $47.94. So far toda ...

Watch for Continued Gains in Shares of R...

Robert Half International (NYSE:RHI) traded today at a new 52-week high of $53.08. So ...

RPC Looks to Continue to Trade Above its...

RPC (NYSE:RES) traded at a new 52-week high today of $24.50. So far today approximatel ...

Most Popular Video News